Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Jolanta Weaver.

Newcastle AuthorsTitleYearFull text
Dr Sherin Bakhashab
Rosie Barber
Josie O'Neill
Dr Catherine Arden
Dr Jolanta Weaver
et al.
Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression2024
Dr Sherin Bakhashab
Josie O'Neill
Rosie Barber
Dr Catherine Arden
Dr Jolanta Weaver
et al.
Upregulation of Anti-Angiogenic miR-106b-3p Correlates Negatively with IGF-1 and Vascular Health Parameters in a Model of Subclinical Cardiovascular Disease: Study with Metformin Therapy2024
Jason Phowira
Nicholas Vennart
Dr Jolanta Weaver
Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up2022
Jason Phowira
Dr Sherin Bakhashab
Anuradha Doddaballapur
Dr Jolanta Weaver
Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function2022
Nicholas Vennart
Dr Jolanta Weaver
Dr Salman Razvi
The prevalence and significance of non-uniform thyroid radio-isotope uptake in patients with Graves’ disease2022
Jason Phowira
Dr Fahad Ahmed
Dr Sherin Bakhashab
Dr Jolanta Weaver
Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study2022
Dr Sherin Bakhashab
Jevi Latief
Dr Jolanta Weaver
MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus)2021
Alice Tamara
Jevi Latief
Dr Jolanta Weaver
Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health2021
Sabby Ray
Alice Tamara
Jevi Latief
Dr Sherin Bakhashab
Dr Jolanta Weaver
et al.
The role of miR-342 in vascular health. Study in subclinical cardiovascular disease in mononuclear cells, plasma, inflammatory cytokines and PANX22020
Professor Philip Preshaw
Dr John Taylor
Dr Katrin Jaedicke
Dr Susan Bissett
Paiboon Jitprasertwong
et al.
Treatment of periodontitis reduces systemic inflammation in type 2 diabetes2020
Dr Arjola Bano
Dr Earn Gan
Dr Jolanta Weaver
Dr Salman Razvi
Age may influence the impact of TRAbs on thyroid function and relapse-risk in patients with Graves’ disease2018
Dr Fahad Ahmed
Dr Sherin Bakhashab
INDA Bastaman
Dr Rachel Crossland
Dr Michael Glanville
et al.
Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study2018
Dr Sherin Bakhashab
Dr Fahad Ahmed
Dr Michael Glanville
Dr Jolanta Weaver
Proangiogenic effect of metformin in endothelial cells is via upregulation of VEGFR1/2 and their signaling under hyperglycemia-hypoxia2018
Dr Andy Colman
Dr Jolanta Weaver
Use of Quick Response (QR) coded bracelets and cards for the improvement of cortisol deficiency/Addison's disease management: an audit of quality of care of the management of steroid deficiency in acute illness2018
Dr Fahad Ahmed
Rachel Rider
Dr Michael Glanville
Dr Salman Razvi
Dr Jolanta Weaver
et al.
Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study2016
Sherin Bakhashab
Dr Fahad Ahmed
Dr Jolanta Weaver
Metformin improves the angiogenic potential of human CD34+cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction2016
Dr Sherin Bakhashab
Dr Jolanta Weaver
Microarray expression profiling identifies genes, including cytokines, and biofunctions, as diapedesis, associated with a brain metastasis from a papillary thyroid carcinoma2016
Dr Sviatlana Zhyzhneuskaya
Dr Jolanta Weaver
Dr Salman Razvi
The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds2016
Dr Daniel West
Professor Mark Walker
Professor James Shaw
Dr Fahad Ahmed
Stephanie Wijaya
et al.
Inflammation and the acute endothelial progenitor cell response to submaximal running exercise in males with and without Type 1 diabetes2015
Dr Asgar Madathil
Dr Kieren Hollingsworth
Professor Andrew Blamire
Dr Salman Razvi
Emerita Professor Julia Newton
et al.
Levothyroxine Improves Abnormal Cardiac Bioenergetics in Subclinical Hypothyroidism: A Cardiac Magnetic Resonance Spectroscopic Study2015
Dr Anna Mitchell
Katie MacArthur
Dr Jolanta Weaver
Dr Bijayeswar Vaidya
Dr Rebecca Darlay
et al.
Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus2015
Professor Mark Walker
Dr Fahad Ahmed
Stephanie Wijaya
Professor James Shaw
Dr Jolanta Weaver
et al.
The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study2015
Dr Fahad Ahmed
Dr Jolanta Weaver
Metformin improves endothelial progenitor cell number in Type 1 diabetes: MERIT study preliminary report2014
Sherin Bakhashab
Dr Fahad Ahmed
Dr Jolanta Weaver
Reference Genes for Expression Studies in Hypoxia and Hyperglycemia Models in Human Umbilical Vein Endothelial Cells2014
Jedrzej Hoffmann
Dr Karel Fiser
Dr Jolanta Weaver
Ian Dimmick
Monika Loeher
et al.
High-Throughput 13-Parameter Immunophenotyping Identifies Shifts in the Circulating T-Cell Compartment Following Reperfusion in Patients with Acute Myocardial Infarction2012
Dr Salman Razvi
Dr Jolanta Weaver
Dr Tim Butler
Professor Simon Pearce
Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality2012
Dr Shaikh Abdul Shakoor
Dr Ali Aldibbiat
Lorna Ingoe
Dr Susan Campbell
Dr Latika Sibal
et al.
Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy2010
Dr Salman Razvi
Dr Jolanta Weaver
Professor Simon Pearce
Subclinical thyroid disorders: significance and clinical impact2010
Dr Salman Razvi
Dr Jolanta Weaver
Professor Simon Pearce
The Incidence of Ischemic Heart Disease and Mortality in People with Subclinical Hypothyroidism: Reanalysis of the Whickham Survey Cohort2010
Dr Latika Sibal
Dr Ali Aldibbiat
Dr Sharad Agarwal
Crispian Oates
Dr Salman Razvi
et al.
Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria2009
Dr Jolanta Weaver
Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study)2009
Dr Akheel Syed
Dr Christina Halpin
Professor Julie Irving
Professor Nigel Unwin
Professor Martin White
et al.
A common intron 2 polymorphism of the glucocorticoid receptor gene is associated with insulin resistance in men2008
Dr Jolanta Weaver
Classical endocrine diseases causing obesity2008
Dr Jolanta Weaver
Classical endocrine diseases causing obesity2008
Dr Salman Razvi
Dr Jolanta Weaver
Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: The ThyDQoL and ThySRQ2008
Dr Akheel Syed
Dr Chris Redfern
Dr Jolanta Weaver
In vivo and in vitro glucocorticoid sensitivity in obese people with cushingoid appearance2008
Hannah Fraser
Professor Philip Preshaw
Professor Roy Taylor
Dr Jolanta Weaver
Dr Rebecca Wassall
et al.
Oral Hygiene and Periodontal Health in Type 1 Diabetes Patients2008
Dr Salman Razvi
Dr Jolanta Weaver
Professor Simon Pearce
The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: A metaanalysis2008
Dr Latika Sibal
Dr Ali Aldibbiat
Crispian Oates
Dr Jolanta Weaver
Professor James Shaw
et al.
The influence of the presence of retinopathy on the circulating endothelial progenitor cell counts, endothelial function and carotid intima-media thickness in type I diabetes2008
Dr Jolanta Weaver
Applicability of estimated glomerular filtration rate in stratifying chronic kidney disease2007
Dr Latika Sibal
Dr Ali Aldibbiat
Dr Jolanta Weaver
Dr Salman Razvi
Crispian Oates
et al.
Endothelial dysfunction and circulating endothelial progenitor cells in young people with type 1 diabetes2007
Dr Latika Sibal
Dr Ali Aldibbiat
Dr Sharad Agarwal
Dr Jolanta Weaver
Dr Salman Razvi
et al.
Endothelial dysfunction, carotid intima media thickness and circulating endothelial progenitor cells in young people with Type 1 diabetes2007
Dr Jolanta Weaver
RCT of continuous glucose monitoring devices on HbA(1C) - The MITRE study2007
Dr Salman Razvi
Lorna Ingoe
Crispian Oates
Dr Jolanta Weaver
The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: Randomized, crossover trial2007
Dr Jolanta Weaver
Use and acceptability of two minimally invasive continuous blood glucose monitors2007
Dr Akheel Syed
Professor Julie Irving
Dr Chris Redfern
Dr Andrew Hall
Professor Nigel Unwin
et al.
Association of glucocorticoid receptor polymorphism A3669G in exon 9β with reduced central adiposity in women2006
Dr Jolanta Weaver
Borderline thyroid function tests: so easy to look at, so hard to define2006
Dr Salman Razvi
Dr Jolanta Weaver
Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: The ThyTSQ2006
Dr Jolanta Weaver
Dr Salman Razvi
Dose of anti-thyroid drugs can effect remission in grave's disease2005
Dr Akheel Syed
Dr Jolanta Weaver
Glucocorticoid sensitivity: The hypothalamic-pituitary-adrenal-tissue axis2005
Dr Salman Razvi
Lorna Ingoe
Dr Jolanta Weaver
Health status in patients with sub-clinical hypothyroidism2005
Dr Salman Razvi
Dr Jolanta Weaver
Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: A systematic qualitative review2005
Dr Jolanta Weaver
Obesity, cytokines and the search for beauty2005
Dr Jolanta Weaver
Dr Salman Razvi
The detrimental effect of anti-thyroid drugs on the outcome of radioiodine therapy is not directly due to decreased radioiodine uptake [2] (multiple letters)2005
Dr Akheel Syed
Dr Chris Redfern
Dr Jolanta Weaver
Aldosterone revisited2004
Dr Salman Razvi
Dr Jolanta Weaver
Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism2004
Dr Bakri Saeed
Dr Andrew Skillen
Dr Jolanta Weaver
Fasting homocysteine levels in adults with type 1 diabetes and retinopathy2004
Dr Akheel Syed
Dr Jolanta Weaver
Insulin resistance and coronary artery disease: Body mass index may have affected results2004
Dr Akheel Syed
Dr Jolanta Weaver
Insulin resistance and coronary artery disease: lean subjects should be used as controls2004
Dr Salman Razvi
Dr Elizabeth McIntyre
Dr S Wahid
Dr Jolanta Weaver
Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: The Gateshead protocol2004
Dr Salman Razvi
Dr Elizabeth McIntyre
Dr Jolanta Weaver
Low failure rate of fixed dose 400 MBq131I with pre-treatment with Carbimazole for thyrotoxicosis; The Gateshead protocol2004
Dr Akheel Syed
Professor Julie Irving
Dr Chris Redfern
Dr Andrew Hall
Professor Nigel Unwin
et al.
Low Prevalence of the N363S Polymorphism of the Glucocorticoid Receptor in South Asians Living in the United Kingdom2004
Dr Jolanta Weaver
Metabolic syndrome; a new disease2004
Dr Jolanta Weaver
Metabolic Syndrome; new disease2004
Dr Jolanta Weaver
Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 842004
Dr Salman Razvi
Dr Jolanta Weaver
Subclinical hypothyroidism and cardiovascular risk2004
Dr Jolanta Weaver
Subclinical hypothyroidism and cardiovascular risk [1] (multiple letters)2004
Dr Jolanta Weaver
The Prospective Pioglitazone Clinical Trial in Macrovascular Events (Proactive)2004
Dr Jolanta Weaver
Dr Salman Razvi
Withdrawal of anti-thyroid drugs (ATD) in a retrospective analysis of patients treated for Graves’s thyrotoxicosis.2004
Dr Jolanta Weaver
Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL study2003
Dr Jolanta Weaver
Losartan Reduces the Cost Associated with Diabetic End-stage Renal Disease2003
Dr Bakri Saeed
Dr Jolanta Weaver
Comparison of two direct methods for HDL-chlesterol measurement with an indirect precipitation method in diabetic patients2002
Dr Jolanta Weaver
Influence of Growth Hormone on Accretion of Bone Mass2002
Dr Jolanta Weaver
MicroAlbuminuria Reduction with Valsartan in patients with type 2 diabetes mellitus2002
Javed Sultan
Dr Bakri Saeed
Dr Jolanta Weaver
Serum fructosamine is a marker of 5-year risk of developing diabetes mellitus in patients exhibiting stress hyperglycaemia2002
Dr Bakri Saeed
Dr Jolanta Weaver
Severe hyponatraemia: investigation and management in a district general hospital2002
Dr Jolanta Weaver
Are we in danger from an epidemic of Cushing's syndrome? Nature knows its course2001
Dr Jolanta Weaver
The influence of gender on the short and long term effects of growth hormone replacement on bone metabolism and bone density in hypopituitary adults: 5 year study2001
Dr Mark Dobson
Dr Chris Redfern
Professor Nigel Unwin
Dr Jolanta Weaver
The N363S polymorphism of the glucocorticoid receptor: Potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus2001
Professor Roy Taylor
Dr Jolanta Weaver
Appropriate insulin regimes for type 2 diabetes: A multicenter randomized crossover study2000
Professor Roy Taylor
Dr Jolanta Weaver
Appropriate Insulin Regimes for Type 2 Diabetes: a multicenter randomized crossover study2000
Dr Jolanta Weaver
The losartan renal protection study - rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)2000